Replies to post #1008 on Tetraphase Pharmaceuticals, Inc. (TTPH)

[lowman]

Their burn rate was around $20M p/Q for the last 2 Q's so I figure they should be down around $200M for fiscal year end. If it comes in around $190M-$195M, I'd assume they paid for the NDA, which costs $5M itself, I believe.